These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1617 related articles for article (PubMed ID: 19408605)

  • 1. Comparison between continuous ambulatory arterial blood pressure monitoring and standard blood pressure measurements among patients of younger and older age group.
    Babić BK; Bagatin J; Kokić S; Ostojić SB; Carević V; Berović N
    Coll Antropol; 2009 Mar; 33(1):65-70. PubMed ID: 19408605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study.
    Mallion JM; Genès N; Vaur L; Clerson P; Vaïsse B; Bobrie G; Chatellier G
    J Hum Hypertens; 2001 Dec; 15(12):841-8. PubMed ID: 11773986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Level of blood pressure control in a hypertensive population when measurements are performed outside the clinical setting.
    Félix-Redondo FJ; Fernández-Bergés D; Espinosa-Garcia J; Pozuelos-Estrada J; Molina-Martínez LM; Pérez-Castán JF; Ríos-Rivera J; Valiente-Rubio JI; Gómez-de-la-Cámara A; Rodríguez-Pascual N
    Cardiol J; 2009; 16(1):57-67. PubMed ID: 19130417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients.
    Kato T; Horio T; Tomiyama M; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y
    Nephrol Dial Transplant; 2007 Mar; 22(3):911-6. PubMed ID: 17142262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated office blood pressure controls reduce the prevalence of white-coat hypertension and detect a group of white-coat normotensive patients.
    Fogari R; Corradi L; Zoppi A; Lusardi P; Poletti L
    Blood Press Monit; 1996 Feb; 1(1):51-54. PubMed ID: 10226202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors for the white coat effect in general practice patients with suspected and treated hypertension.
    Lindbaek M; Sandvik E; Liodden K; Mjell J; Ravnsborg-Gjertsen K
    Br J Gen Pract; 2003 Oct; 53(495):790-3. PubMed ID: 14601355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of the white-coat effect in hypertensive subjects.
    Mansoor GA; McCabe EJ; White WB
    J Hum Hypertens; 1996 Feb; 10(2):87-92. PubMed ID: 8867561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ambulatory blood pressure monitoring to study white coat syndrome in patients with hypertension seen in primary care].
    Villalba Alcalá F; Lapetra Peralta J; Mayoral Sánchez E; Espino Montoro A; Cayuela Domínguez A; López Chozas JM
    Rev Esp Cardiol; 2004 Jul; 57(7):652-60. PubMed ID: 15274850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of home pressure monitoring in the treatment hypertension in the practice of general medicine].
    Widimský J; Balazovjech I; Lánská V
    Vnitr Lek; 1999 Oct; 45(10):569-77. PubMed ID: 10951863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association.
    Pickering TG; Miller NH; Ogedegbe G; Krakoff LR; Artinian NT; Goff D; ; ;
    J Cardiovasc Nurs; 2008; 23(4):299-323. PubMed ID: 18596492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White coat effect in treated hypertensive patients: sex differences.
    Myers MG; Reeves RA
    J Hum Hypertens; 1995 Sep; 9(9):729-33. PubMed ID: 8551486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is ambulatory blood pressure monitoring cost-effective in the routine surveillance of treated hypertensive patients in primary care?
    Lorgelly P; Siatis I; Brooks A; Slinn B; Millar-Craig MW; Donnelly R; Manning G
    Br J Gen Pract; 2003 Oct; 53(495):794-6. PubMed ID: 14601356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ["White-coat hypertension": variation of normality or of hypertension?].
    Carmona J; Amado P; Vasconcelos N; Santos I; Pinto C; Forte G; Arsénio A; Nazaré J
    Rev Port Cardiol; 1998 Jun; 17(6):505-12. PubMed ID: 9677828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-measurement of blood pressure in arterial hypertension--preliminary results from the AMPA study.
    Maldonado J; Pereira T;
    Rev Port Cardiol; 2009 Jan; 28(1):7-21. PubMed ID: 19388489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of clinical and ambulatory measurements of blood pressure with benazepril alone or combined with hydrochlorothiazide in hypertension].
    Le Feuvre C; Francillon A; Renucci JF; Cocco-Guyomarch L; Muller M; Peuplier P; Poggi L
    Therapie; 1996; 51(1):27-34. PubMed ID: 8762217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White-coat hypertension in adults and children.
    Verdecchia P
    Blood Press Monit; 1999; 4(3-4):175-9. PubMed ID: 10490871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Is prevalence of the "white coat effect" correlated with a high risk of late diabetic complications in type 2 diabetic patients?].
    Mozdzan M; Ruxer J; Barański M; Roszczyk N; Markuszewski L
    Ann Acad Med Stetin; 2008; 54(1):65-9; discussion 69. PubMed ID: 19127812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target-organ damage and cardiovascular risk profile in resistant hypertension. Influence of the white-coat effect.
    Hernández-delRey R; Armario P; Martin-Baranera M; Sánchez P; Cárdenas G; Pardell H
    Blood Press Monit; 1998; 3(6):331-7. PubMed ID: 10212374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 81.